Shares Magazine
21.00p+1.20 (+6.06%)31 May 2024, 13:39
Jump to:
Argent Biopharma Limited Fundamentals
| Company Name | Argent Biopharma Limited | Last Updated | 2024-05-31 |
|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
| Shares in Issue | 45.280 m | Market Cap | £9.51 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -7.10 AUD | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0270 | Debt Equity Ratio | 0.2312 |
| Asset Equity Ratio | 25.8040 | Cash Equity Ratio | 9.6499 |
| Quick Ratio | 0.5652 | Current Ratio | 0.76 |
| Price To Book Value | 13.4590 | ROCE | 0 |
Argent Biopharma Limited Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Argent Biopharma Limited Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | 7.45 m AUD | 8.80 m AUD | 7.14 m AUD |
| Intangible Assets | 0 | 3.15 m AUD | 7.05 m AUD |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | 7.45 m AUD | 12.10 m AUD | 14.75 m AUD |
| Stocks | 1.36 m AUD | 1.84 m AUD | 872,444.00 AUD |
| Debtors | 0 | 0 | 0 |
| Cash & Equivalents | 239,821.00 AUD | 1.89 m AUD | 5.43 m AUD |
| Other Assets | 0 | 0 | 0 |
| Total Assets | 9.98 m AUD | 18.56 m AUD | 24.24 m AUD |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | 13.33 m AUD | 7.71 m AUD | 6.13 m AUD |
| Creditors after 1 year | 4.68 m AUD | 5.67 m AUD | 4.28 m AUD |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | 18.02 m AUD | 13.38 m AUD | 10.41 m AUD |
| Net assets | -8.03 m AUD | 5.18 m AUD | 13.83 m AUD |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | 103.69 m AUD | 97.25 m AUD | 84.51 m AUD |
| Share Premium | 0 | 0 | 0 |
| Profit / Loss | -21.13 m AUD | -20.77 m AUD | -15.44 m AUD |
| Other Equity | -7.40 m AUD | 5.84 m AUD | 13.83 m AUD |
| Preference & Minorities | -628,755.00 AUD | -657,629.00 AUD | -8,648.00 AUD |
| Total Capital Employed | -8.03 m AUD | 5.18 m AUD | 13.83 m AUD |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | 0 | 0.25 AUD | 0.11 AUD |
| Debt-to-Equity | 0 | 0.34 AUD | 0.13 AUD |
| Assets / Equity | 25.8040 | 25.8040 | 25.8040 |
| Cash / Equity | 9.6499 | 9.6499 | 9.6499 |
| EPS | -5.98 AUD | -5.89 AUD | -6.09 AUD |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | 0 | 0 | 0 |
| Cashflow before financing | 0 | 0 | 0 |
| Increase in Cash | -1.66 m AUD | -3.53 m AUD | 3.57 m AUD |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | 3.39 m AUD | 4.73 m AUD | 2.96 m AUD |
| Cost of sales | 1.94 m AUD | 2.92 m AUD | 1.65 m AUD |
| Gross Profit | 1.45 m AUD | 1.81 m AUD | 1.31 m AUD |
| Operating Profit | 0 | 0 | 0 |
| Pre-Tax profit | -21.13 m AUD | -20.77 m AUD | -15.44 m AUD |
Argent Biopharma Limited Company Background
| Sector | Healthcare |
|---|---|
| Activities | Argent Biopharma Ltd is an innovative drug discovery company that addresses unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector. Its products includes CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development. |
| Latest Interim Date | 29 Feb 2024 |
| Latest Fiscal Year End Date | 31 Aug 2023 |
Argent Biopharma Limited Directors
| Appointed | Name | Position |
|---|
Argent Biopharma Limited Contact Details
| Company Name | Argent Biopharma Ltd |
|---|---|
| Address | 1202 Hay Street, West Perth, Perth, 6005 |
| Telephone | +61 863823390 |
| Website | https://www.argentbiopharma.com |
Argent Biopharma Limited Advisors
| Auditor | PKF Mack & Co |
|---|---|
| Phone | +61 8 9426 8999 |
| Fax | +61 8 9426 8900 |
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Me Group International PLC | 182.80 | 5.18 |
| Aston Martin Lagonda Global Holdings PLC | 145.20 | 4.76 |
| National Grid PLC | 882.40 | 4.67 |
| Wizz Air Holdings PLC | 2,292.00 | 4.37 |
| Qinetiq Group PLC | 447.20 | 4.10 |
| Dr. Martens PLC | 87.40 | 4.05 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Ferrexpo PLC | 41.55 | -6.63 |
| Wood Group (John) PLC | 176.90 | -5.45 |
| Auction Technology Group PLC | 522.00 | -5.26 |
| Jd Sports Fashion PLC | 127.50 | -4.71 |
| Associated British Foods PLC | 2,550.00 | -4.14 |
| Marshalls PLC | 316.00 | -2.77 |
Risers/fallers data from previous trading day.